|本期目录/Table of Contents|

[1]李 晗,李继斌,邢正英,等.复方阿托伐他汀依折麦布胶囊的质量控制[J].天津医科大学学报,2016,22(01):76-79.
 LI Han,LI Ji-bing,XING Zheng-ying,et al.Quality control of compound atorvastatin and ezetimibe capsule[J].Journal of Tianjin Medical University,2016,22(01):76-79.
点击复制

复方阿托伐他汀依折麦布胶囊的质量控制(PDF)
分享到:

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
22卷
期数:
2016年01期
页码:
76-79
栏目:
技术与方法
出版日期:
2016-01-20

文章信息/Info

Title:
Quality control of compound atorvastatin and ezetimibe capsule
文章编号:
1006-8147(2016)01-0076-04
作者:

李 晗李继斌邢正英戴学文房志仲


?
(天津医科大学药学院,天津市临床药物关键技术重点实验室,天津 300070)
Author(s):
LI Han LI Ji-bing XING Zheng-ying DAI Xue-wen FANG Zhi-zhong

(College of Pharmacy, Tianjin Medical University, Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics) , Tianjin 300070, China)



关键词:
阿托伐他汀依折麦布高效液相色谱法质量控制含量均匀度
Keywords:
atorvastatinezetimibeHPLCquality controlcontent uniformity
分类号:
R927.2
DOI:
-
文献标志码:
A
摘要:
目的:建立复方阿托伐他汀依折麦布胶囊的质量控制方法。方法:利用HPLC法测定复方阿托伐他汀依折麦布胶囊中主药的含量与制剂的含量均匀度,色谱条件为:TIANHE? Kromasil C18 色谱柱(5 μm,200 mm×4.6 mm);流动相为甲醇-0.05 M KH2PO4(磷酸调节pH至3.0)-乙腈(5:45:50);检测波长为λ=236 nm;流速1.0 mL/min;进样量20 μL;柱温为25 ℃。结果:阿托伐他汀在1.12~16.8 μg/mL的浓度范围内线性关系良好(r=0.999 9),依折麦布在1.14~17.1 μg/mL的浓度范围内线性关系良好(r=0.999 9);阿托伐他汀和依折麦布的平均加样回收率分别为100.58%和100.64%,RSD分别为1.18%和0.92%。结论:该HPLC测定条件和含量测定方法,能够有效测定样品的含量,且简便易行。
Abstract:
Objective: To establish an appropriate method to determine contents of atorvastatin and ezetimibe in compound atorvastatin and ezetimibe capsule. Methods: Content and content uniformity of compound atorvastatin and ezetimibe capsule were determined by an HPLC method, in which a TIANHE? Kromasil C18 column (200 mm×4.6 mm, 5 μm) was used as stationary phase and a mix of methanol-0.05 mol/L KH2PO4 (adjusted to pH 3.0 with phosphoric acid) -acetonitrile (5:45:50) was used as mobile phase. The detection wavelength was 236 nm and flow rate was 1.0 mL/min. Column temperature was set at 25 ℃. Results: The concentration detection of atorvastatin showed a fine linearity between 1.12-16.8 μg/mL (r=0.999 9) , while the concentration detection of ezetimibe showed a fine linearity between 1.14-17.1 μg/mL (r=0.999 9) ; the average recoveries of atorvastatin and ezetimibe were 100.58% and 100.64%, respectively, and corresponding RSD values were 1.18% and 0.92%, respectively. Conclusion: The detection method in this study is simple and accuracy, so it is appropriate to be used in the quality control of the compound atorvastatin and ezetimibe capsule.

参考文献/References:

[1]杜晓明,庞露,孙浩,等. 阿托伐他汀联合依折麦布降脂有效性及安全性Meta分析[J]. 医药导报, 2012,31(8):1007
[2]刘龙华. 阿托伐他汀联合依折麦布治疗高脂血症疗效观察[J]. 右江医学, 2013,41(4):534
[3]刘峰,刘海波. 依折麦布联合阿托伐他汀钙治疗高胆固醇血症的疗效观察[J]. 现代诊断与治疗, 2013,24(17):3909
[4]崔祥祯,任英,吕永超. HPLC法测定阿托伐他汀钙片的含量[J]. 药学研究, 2013,32(6):340
[5]邱思婕. 高效液相法测定依折麦布片的含量[J]. 广州化工, 2012,40(16):134
[6]Sama J R, Kalakuntla R R, Rao V N, et al. Simultaneous estimation of atorvastatin and ezetimibe in pharmaceutical formulations by RP-HPLC method[J]. Der Pharmacia Lettre, 2010,2(1):427
[7]迟敏,黄文杰,张红,等. HPLC法同时测定阿托伐他汀钙、阿司匹林、缬沙坦和苯磺酸氨氯地平制剂的含量[J]. 中国药房, 2014,25(8):749
[8]Kumar P. Stability indicating method development for simultaneous estimation of ezetimibe and atorvastatin in pharmaceutical formulations by RP-HPLC[J]. Pharm Anal Acta. , 2012Suppl 7):S7
[9]Goel A, Baboota S, Sahni J K, et al. Development and validation of stability-indicating assay method by UPLC for a fixed dose combination of atorvastatin and ezetimibe[J]. J Chromatogr Sci, 2013,51(3):222
[10]赖庆宽,王磊,谢婷,等. 依折麦布辛伐他汀片溶出度的 HPLC 法测定[J]. 中国医药工业杂志, 2013,44(12):1275
[11]汪秋兰,王文清,施春阳,等. 高效液相色谱法测定阿托伐他汀钙片中阿托伐他汀钙的含量[J]. 医药导报, 2013,32(3):366
[12]于鑫,周增慧,袁慧雅,等. HPLC同时测定依折麦布辛伐他汀片中两种成分的含量[J]. 中国现代应用药学, 2013,30(9):1008
[13]国家药典委员会.中华人民共和国药典(二部)[S].北京:中国医药科技出版社,2010
[14]李丹丹,陶涛. 他汀类药物化学结构和理化性质对其药效及药动学特性的影响[J]. 中国医药工业杂志, 2012,43(6):497
[15]Taupitz T, Dressman J B, Klein S. New formulation approaches to improve solubility and drug release from fixed dose combinations: case examples pioglitazone/glimepiride and ezetimibe/simvastatin[J]. Eur J Pharm Biopharm. , 2013,84(1):208
[16]Srivalli K R, Mishra B. Improved aqueous solubility and antihypercholesterolemic activity of ezetimibe on formulating with Hydroxypropyl-β-Cyclodextrin and hydrophilic auxiliary substances[J]. AAPS PharmSciTech, 2015 ,[Epub ahead of print]

相似文献/References:

[1]李小龙,万 征.缺血大鼠心肌细胞晚钠电流的变化规律和阿托伐他汀的作用[J].天津医科大学学报,2018,24(04):291.
 LI Xiao-long,WAN Zheng.Effects of atorvastatin on late sodium current in ventricular myocytes in rats suffering from simulated ischemia[J].Journal of Tianjin Medical University,2018,24(01):291.

备注/Memo

备注/Memo:
作者简介 李晗(1990-),男,硕士在读,研究方向:药物制剂与质量控制研究;通信作者:房志仲,E-mail:fangzhizhong@tijmu.edu.cn。
更新日期/Last Update: 2016-01-26